Table 3: Proportion of Women, Patients of Colour and Sex/Race-specific Outcomes in Remote Management Strategies Studies.

Study	Target populations	Location	Women n (%)	Patients of Colour n (%)	Sex/race-specific Findings
TELE-HF (2010)[50]	Prior HF hospitalisation within 1 month	US	695 (40.6)	838 (50.7)	Rehospitalisation or death in women (HR 0.87; 95%CI [0.7–1.07]) and black patients (HR 1.03; 95%CI [0.83–1.28])
TIM-HF (2020)	Prior HF, NYHA II–III, EF ≤ 25% within 6 months, or EF ≤ 35% with HF decompensation within 24 months	Germany	126 (17.7)	NR	NR
TIM-HF2 (2018)[42]	Prior HF hospitalisation within 12 months, NYHA II–III, EF ≤ 45%	Germany	468 (30.4)	NR	All-cause mortality or unplanned rehospitalisation in women (HR 1.02; 95%CI [0.71–1.48])
BEAT-HF (2016)[43]	Prior documented treatment for HF	US	673 (46.8)	654 (45.5)	The 3-month readmission rate was not different in female patients and black patients
LINK-HF (2020)[47]	NYHA II–IV with acute HF exacerbation in hospital	US	2 (2.0)	21 (21.0)	NR

CRT-D = cardiac resynchronisation therapy–defibrillator; EF = ejection fraction; HF = heart failure; NR = not reported; NYHA = New York Heart Association.